Order Article Reprints

Pink D, Andreou D, Bauer S, Brodowicz T, Kasper B, Reichardt P, Richter S, Lindner LH, Szkandera J, Grünwald V, et al. Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient^® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers. 2021; 13(6):1223. https://doi.org/10.3390/cancers13061223

Pink, Daniel, Dimosthenis Andreou, Sebastian Bauer, Thomas Brodowicz, Bernd Kasper, Peter Reichardt, Stephan Richter, Lars H. Lindner, Joanna Szkandera, Viktor Grünwald, and et al. 2021. "Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient^® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)" Cancers 13, no. 6: 1223. https://doi.org/10.3390/cancers13061223

Pink, D., Andreou, D., Bauer, S., Brodowicz, T., Kasper, B., Reichardt, P., Richter, S., Lindner, L. H., Szkandera, J., Grünwald, V., Kebenko, M., Kirchner, M., & Hohenberger, P. (2021). Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient^® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers, 13(6), 1223. https://doi.org/10.3390/cancers13061223